The purpose of this single arm clinical trial is to evaluate the effects of 7% hypertonic saline (HS) delivered by nebulizer on clearance of mucus from the lun…

BronchiectasisNon-cystic Fibrosis Bronchiectasis

~Estimated

~$10 – $6,250

University of North Carolina, Chapel HillNCT06242795

Phase 2

A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People With Cystic Fibrosis

ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy …

Cystic FibrosisCFTR Gene Mutation

~Estimated

~$10 – $8,750

Arcturus Therapeutics, Inc.NCT06747858

Phase 2

An Open Label Clinical Trial of Metformin in Those With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)

Cystic Fibrosis-related DiabetesCystic Fibrosis

~Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT04530383

← PreviousPage 8 of 8Next →